p53 as a Neoplastic Biomarker in Patients with Erosive and Plaque Like Forms of Oral Lichen Planus
Iraj Mirzaii-Dizgah, Farzaneh Agha-Hosseini
Citation Information :
Mirzaii-Dizgah I, Agha-Hosseini F. p53 as a Neoplastic Biomarker in Patients with Erosive and Plaque Like Forms of Oral Lichen Planus. J Contemp Dent Pract 2013; 14 (1):1-3.
Unstimulated whole salivary p53 was assessed in patients suffering from erosive and plaque-like form of oral lichen planus (OLP).
Materials and methods
Eighteen patients with erosive form, 17 patients suffering from plaque-like form and 38 noninvolvement subjects were enrolled. The unstimulated whole saliva p53 level was assayed by ELISA.
Results
The mean concentration of salivary p53 was significantly higher in patients with plaque-like form compared to both patients with erosive form and the control group.
Conclusion
We conclude that plaque like form of OLP is important in view of the potential for malignancy and is not safety form.
Clinical significance
It seems that all forms of OLP must be considered accurately, should be followed up with biannual examinations, and if possible, assessment of salivary p53 every year.
How to cite this article
Agha-Hosseini F, Mirzaii-Dizgah I. p53 as a Neoplastic Biomarker in Patients with Erosive and Plaque Like Forms of Oral Lichen Planus. J Contemp Dent Pract 2013;14(1):1-3.
Efficacy of purslane in the treatment of oral lichen planus. Phytother Res 2010;24(2):240-44.
Increased salivary lipid peroxidation in human subjects with oral lichen planus. Int J Dent Hyg 2009;7(4):246-50.
Immunohistochemistry Analysis of P53 and Ki-67 Proteins in Oral Lichen Planus and Normal Oral Mucosa. Iranian J Publ Health 2009;38(2):37-43.
Expression of novel p53 isoforms in oral lichen planus. Oral Oncol 2008;44(2):156-61.
Treatment of oral erosive lichen planus with systemic isotretinoin. Oral Surg Oral Med Oral Pathol 1986;62(4):393-96.
Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103 Suppl:S25.e1-12.
p53, mdm2, and p21 expression in oral squamous cell carcinomas: Relationship with clinicopathologic factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94(5):593-600.
Correlation of serum and salivary CA125 levels in patients with breast cancer. J Contemp Dent Pract 2009;10(6):E001-8.
Correlation of serum and salivary CA15-3 levels in patients with breast cancer. Med Oral Patol Oral Cir Bucal 2009;14(10):e521-24.
Saliva as a diagnostic fluid. Oral Dis 2002;8(2):69-76.
The composition of unstimulated whole saliva of healthy dental students. J Contemp Dent Pract 2006;7(2):104-11.
Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99(4):471-78.
Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues. Oral Oncol 2006;42(2):147-53.
An immunohistochemical analysis of p53 protein expression in premalignant and malignant tissues of the oral cavity. Clin Otolaryngol Allied Sci 1997;22(1):23-29.
Detection of apoptotic cells in whole saliva of patients with oral premalignant and malignant lesions: A preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97(4):465-70.
Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas. Oral Oncol 2000;36(3):272-76.
The clinical features, malignant potential, and systemic associations of oral lichen planus: A study of 723 patients. J Am Acad Dermatol 2002;46(2):207-14.
Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: A 5-year experience. Oral Oncol 2001;37(3):262-67.
High proliferative activity and chromosomal instability in oral lichen planus. Int J Oral Maxillofac Surg 2006; 35(12):1140-44.